“…[14] Untreated GDM results in adverse maternal and fetal outcomes such as increased risk of preterm delivery, preeclampsia, macrosomia or large for gestational age (a known risk factor for birth injury), operative delivery, stillbirth, respiratory distress syndrome, and neonatal hypoglycaemia. [15] The oral glucose tolerance test (OGTT) is considered to be the gold standard for diagnosis of GDM and is superior to fasting plasma glucose (FPG) and the glycosylated haemoglobin (HbA1c) level. [16] However, the OGTT has its limitations including cost, the time required for the test and the unpleasant side-effects due to the high glucose load.…”